1. Home
  2. Browse
  3. Diabetes & Endocrinology
  4. Resources
  5. Charts

Charts

31 - 43 of 43 Results
Sort Results:
Commentary: Cycloset: A New Bromocriptine Formulation for Diabetes February 2011
Commentary: Insulins March 2010
Commentary: New Drug: Victoza (Liraglutide) March 2010
Other: Pancreatitis and Byetta (Exenatide) November 2009
Commentary: New Drug: Onglyza (Saxagliptin) September 2009
Commentary: Is Lantus Associated With An Increased Risk of Cancer? August 2009
Commentary: How Much Insulin Is Too Much? January 2009
Guideline: ADA Position Statement on Standards of Medical Care in Diabetes - 2008 November 2008
Guideline: 2008 ADA Consensus Statement on Management of Hyperglycemia in Type 2 Diabetes November 2008
Commentary: Insulin Use in Patients with Type 2 Diabetes November 2008
Other: Info for Healthcare Providers About the Discontinuation of Exubera November 2007
Commentary: Exubera Off the Market November 2007
Commentary: Avandia (Rosiglitazone) and the Risk of Myocardial Infarction July 2007